Patent ID: 9687551
Date: 2017-06-27
CPC Classifications: A61K,A61P

Claim:
1. A method of reducing a gastrointestinal (GI) toxic effect of a non-steroidal anti-inflammatory drug (NSAID) in a subject who ingests the NSAID, comprising administering to the subject a pharmaceutical composition which is an NSAID-in-oil suspension, wherein: (a) the NSAID-in-oil suspension is the product of a process that comprises admixing an NSAID in powder form into a lecithin oil; (b) the NSAID-in-oil suspension comprises from about 20 wt. % to about 80 wt. % phospholipids; (c) the NSAID in the NSAID-in-oil suspension is present in a therapeutically effective amount; and (c) the NSAID-in-oil suspension has a GI toxicity that is reduced relative to the NSAID alone.